Ribozyme and omics

Anti-cancer development based on RNA Platform technology Core competence to meet diverse unmet medical needs

Advantages of technology

Improved HCC specificity
HCC-selective expression of therapeutic RNA through specific replacement of hTERT RNA with therapeutic RNA

Multiple antitumor effects
Removal of cancer cell hTERT RNA and simultaneous expression of therapeutic RNA

hTERT targeting
Effective application to heterogenous cancer cells through targeting hTERT expressed in 80 ~ 90% of HCC

Improved anticancer efficacy
Use of HSVtk as therapeutic gene: Cancer regression, bystander effect, and cancer immunity induction

Indication expansion
Expand the indication for various carcinomas. Modular engineering → Apply to various diseases